Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity

BMC Cell Biology - Tập 2 - Trang 1-9 - 2001
Gaetan A Turenne1, Brendan D Price1
1Department of Radiation Oncology, D810A, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA

Tóm tắt

The p53 protein is activated by genotoxic stress, oncogene expression and during senescence, p53 transcriptionally activates genes involved in growth arrest and apoptosis. p53 activation is regulated by post-translational modification, including phosphorylation of the N-terminal transactivation domain. Here, we have examined how Glycogen Synthase Kinase (GSK3), a protein kinase involved in tumorigenesis, differentiation and apoptosis, phosphorylates and regulates p53. The 2 isoforms of GSK3, GSK3α and GSK3β, phosphorylate the sequence Ser-X-X-X-Ser(P) when the C-terminal serine residue is already phosphorylated. Several p53 kinases were examined for their ability to create GSK3 phosphorylation sites on the p53 protein. Our results demonstrate that phosphorylation of serine 37 of p53 by DNA-PK creates a site for GSK3β phosphorylation at serine 33 in vitro. GSK3α did not phosphorylate p53 under any condition. GSK3β increased the transcriptional activity of the p53 protein in vivo. Mutation of either serine 33 or serine 37 of p53 to alanine blocked the ability of GSK3β to regulate p53 transcriptional activity. GSK3β is therefore able to regulate p53 function in vivo. p53's transcriptional activity is commonly increased by DNA damage. However, GSK3β kinase activity was inhibited in response to DNA damage, suggesting that GSK3β regulation of p53 is not involved in the p53-DNA damage response. GSK3β can regulate p53's transcriptional activity by phosphorylating serine 33. However, GSK3β does not appear to be part of the p53-DNA damage response pathway. Instead, GSK3β may provide the link between p53 and non-DNA damage mechanisms for p53 activation.

Tài liệu tham khảo

Canman CE, Lim D-S: The role of ATM in DNA damage responses to cancer. Oncogene. 1998, 17: 3301-3308. 10.1038/sj.onc.1202577.

Lowe SW: Activation of p53 by Oncogenes. Endocr Relat. 1999, 6: 45-48. 10.1677/erc.0.0060045.

Lundberg AS, Hahn WC, Gupta P, Weinberg RA: Genes involved in senescence and immortalization. Curr Opin Cell Biol. 2000, 12: 705-709. 10.1016/S0955-0674(00)00155-1.

Vousden KH: p53:death star. Cell. 2000, 103: 691-694. 10.1016/S0092-8674(00)00171-9.

Vogelstein B, Lane D, Levine AJ: Surfing the p53 network. Nature. 2001, 108: 307-310.

Haupt Y, Maya R, Kazaz A, Oren M: Mdm2 promotes the rapid degradation of p53. Nature. 1997, 387: 296-299. 10.1038/387296a0.

Kubbutat MCG, Jones SN, Vousden KH: Regulation of p53 stability by mdm2. Nature. 1997, 387: 299-303. 10.1038/387299a0.

Pomerantz J, Schreiber-Agus N, Liegeosis NJ, Silverman A, AIIand L, Chin L, Potes J, Chen K, Orlow I, Lee H-W, Cordon-Cardo C, DePinho RA: The lnk4a tumor suppressor gene product p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 1998, 92: 713-723. 10.1016/S0092-8674(00)81400-2.

Meyn MS: Ataxia Telangiectasia, cancer and the pathobiology of the ATM gene. Clin Genet. 1999, 55: 289-304. 10.1034/j.1399-0004.1999.550501.x.

Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L, Smorodinsky Nl, Prives C, Reiss Y, Shiloh Y, Ziv Y: Enhanced phosphorylation of p53 byATM in response to DNA damage. Science. 1998, 281: 1674-1678. 10.1126/science.281.5383.1674.

Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, Siliciano JD: Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 1998, 281: 1677-1682. 10.1126/science.281.5383.1677.

Matsuoka S, Huang M, Elledge SJ: Linkage of ATM to cell cycle regulation by the chk2 protein kinase. Science. 1998, 282: 1893-1897. 10.1126/science.282.5395.1893.

Shieh S-Y, Ahn J, Tamai K, Taya Y, Prives C: The human homologs of checkpoint kinases Chk1 and Cds1 (chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 2000, 14: 289-300.

Chebab NH, Malikzay A, Appel M, Halozonetis TD: Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev. 2000, 14: 278-288.

Shieh S-Y, Taya Y, Prives C: DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 1999, 18: 1815-1823. 10.1093/emboj/18.7.1815.

Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A, Anderson CW, Appella E: DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 1998, 12: 2831-2841.

Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E, Kastan MB: DNA damage induces phosphorylation of the amino-terminus of p53. Genes Dev. 1997, 11: 3471-3481.

Shieh S-Y, Ikeda M, Taya Y, Prives C: DNA-damage induced phosphorylation of p53 alleviates inhibition by mdm2. Cell. 1997, 91: 325-334. 10.1016/S0092-8674(00)80416-X.

Gu W, Roeder RG: Activation of p53-sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 1997, 90: 595-606. 10.1016/S0092-8674(00)80521-8.

Steegenga WT, van der Eb AJ, Jochemsen AG: How phosphorylation regulates the activity of p53. J.Mol. Biol. 1996, 263: 103-113. 10.1006/jmbi.1996.0560.

Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y: p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell. 2000, 102: 849-862. 10.1016/S0092-8674(00)00073-8.

Higashimto H, Saito S, Tong XH, Hong A, Sakaguchi K, Appella E, Anderson CW: Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J Biol Chem. 2000, 275: 23199-23203. 10.1074/jbc.M002674200.

Franke TF, Kaplan DR, Cantley LC: PI3K: Downstream Aktion blocks apoptosis. Cell. 1997, 88: 435-437. 10.1016/S0092-8674(00)81883-8.

Kirn L, Kimmel AR: GSK3, a master switch regulating cell-fate specification and tumorigenesis. Curr Opin Gen Dev. 2000, 10: 508-514. 10.1016/S0959-437X(00)00120-9.

Kennedy SG, Wagner AJ, Conzen SD, Jordan J, Bellacosa A, Tsichlis PN, Hay N: The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997, 11: 701-713.

Neal JW, Clipstone NA: Glycogen Synthase kinase-3 inhibits the DNA binding activity of NFATc. J Biol Chem. 2000, 276: 3666-3673. 10.1074/jbc.M004888200.

Xavier LJ, Mercier PA, McLoughlin CM, AIi A, Woodgett JR, Ovsenek N: Glycogen Synthase Kinase 3β negatively regulates both DNA-Binding and transcriptional activities of Heat Shock factor-1. J Biol Chem. 2000, 275: 29147-29152. 10.1074/jbc.M002169200.

Eldar-Finkelman H, Argast GM, Foord B, EH Fischer, EG Krebbs: Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells. Proc NatI Acad. 1996, 93: 1028-10233.

Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995, 378: 785-789. 10.1038/378785a0.

Meek DW, Simon S, Kikkawa U, W Eckhart: The p53 tumor suppresser protein is phosphorylated at serine 389 by casein kinase II. EMBO J. 1994, 9: 3253-3260.

Miller DM, Campbell DG, Caudwell FB, Meek DW: Phosphorylation of the tumor suppressor p53 by mitogen activated kinases. J Biol Chem. 1994, 269: 9253-9260.

Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E, Anderson CW: Human DNA activated protein kinase phosphorylates serines 15 and 37 in the amino terminal transactivation domain of human p53. Mol Cell Biol. 1992, 12: 5041-5049.

Youmell M, Park SJ, Basu S, Price BD: Regulation of the p53 protein by protein kinase Cα and protein kinase Cε. Biochem Biophys Res Comm. 1998, 245: 514-518. 10.1006/bbrc.1998.8471.

Adler V, Pincus MR, Minamoto T, Fuchs SY, Bluth MJ, Brandt-Rauf T, Friedman FK, Robison RC, Chen JM, Wang XW, Harris CC, Ronai Z: Conformation-dependent phosphorylation of p53. Proc NatI Acad Sci. 1997, 94: 1686-1691. 10.1073/pnas.94.5.1686.

Fuchs SY, Adler V, Buschman T, Yin Z, Wu X, Jones SN, Ronai Z: JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 1998, 12: 2658-2663.

Woodgett JR: Molecular cloning and expression of glycogen synthase kinase-3/Factor A. EMBO J. 1990, 9: 2431-2438.

Hoeflich KP, Luo J, Ruble EA, Tsao M-S, Jin U, JR Woodgett: Requirement for glycogen synthase kinase-3β in cell survival and NF-κ B activation. Nature. 2000, 406: 86-90. 10.1038/35017574.

Unger T, Sionov RV, Moallen E, Yee CL, Howley PM, Oren M, Haupt Y: Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene. 1999, 18: 3205-3212. 10.1038/sj.onc.1202656.

Ashcroft M, Kubbutata HG, Vousden KH: Regulation of p53 function and stability by phosphorylation. Mol. Cell Biol. 1999, 19: 1751-1758.

Blattner C, Tobiasch E, Litfen M, Rahmsdorf HJ, Herrlich P: DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation. Oncogene. 1999, 18: 1723-1732. 10.1038/sj.onc.1202480.

Featherstone C, Jackson SP: DNA-dependent protein kinase gets a break: its role in repairing DNA and maintaining genomic integrity. Br J Cancer. 1999, 80 Suppl(1): 14-19.

Woo RA, McLure KG, Lees-Miller SP, Rancourt DE, Lee PW: DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature. 1998, 394: 700-704. 10.1038/29343.

Jimenez GS, Bryntesson F, Torres-Arzayus Ml, Priestly A, Beche M, Sakaguchi K, Appella E, Jeggo PA, Taccioli GE, Wahl GM, Hubank F: DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature. 1999, 400: 81-83. 10.1038/21913.

Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh S-Y, Taya Y, Prives C, Abraham RT: A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 1999, 13: 152-157.

Jayaraman L, Tamai K, Taya Y, Prives C, ZQ Pan: p53 is phosporylated by CDK7-cyclin H in a p36mat1 dependent manner. Mol Cell Biol. 1997, 17: 7220-7229.

Sanchez-Prieto R, Rojas JM, Taya Y, Gutkind JS: A role for p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Research. 2000, 60: 2464-2472.

Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three akts. Genes Dev. 1999, 13: 2905-2927. 10.1101/gad.13.22.2905.

Mazzoni IE, Said FA, Aloyz R, Miller FD, Kaplan D: Ras regulates sympathetic neuron survival by suppressing the p53-mediated cell death pathway. J Neuro. 1999, 19: 9716-9727.

Sabbatini P, McCormick F: Phosphoinositide 3-OH kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J Biol Chem. 1999, 274: 24263-24269. 10.1074/jbc.274.34.24263.

Yamaguchi A, Tamatani M, Matsuzuki H, Namikawa K, Kiyama H, Vitek MP, Mitsuda N, Tohyama M: Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53. J Biol Chem. 2001, 276: 5256-5264. 10.1074/jbc.M008552200.

Thông tin
Thông tin xuất bản

BMC Cell Biology

Tập 2

1-9

Thông tin tác giả